UBS O'Connor’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,630
| Closed | -$166K | – | 445 |
|
|
2024
Q1 | $166K | Sell |
32,630
-27,529
| -46% | -$140K | ﹤0.01% | 377 |
|
|
2023
Q4 | $360K | Sell |
60,159
-181,661
| -75% | -$1.09M | 0.01% | 366 |
|
|
2023
Q3 | $1.71M | Buy |
241,820
+9,357
| +4% | +$66.2K | 0.03% | 262 |
|
|
2023
Q2 | $1.64M | Buy |
232,463
+6,699
| +3% | +$47.2K | 0.03% | 325 |
|
|
2023
Q1 | $1.88M | Buy |
+225,764
| New | +$1.88M | 0.04% | 330 |
|
|
2022
Q4 | – | Sell |
-216,327
| Closed | -$2.73M | – | 50 |
|
|
2022
Q3 | $2.73M | Sell |
216,327
-20,000
| -8% | -$252K | 0.03% | 465 |
|
|
2022
Q2 | $2.5M | Buy |
+236,327
| New | +$2.5M | 0.03% | 599 |
|